News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Look at this!
Last days of the $2s IMO. It's likely that we won't see anything with a 2 in front of it again. If the stock wasn't so heavily manipulated, we would already be in the $3s today. We are losing ground again right now as they are taking us down at about the same time as yesterday. The first sucker punch came now and the second about 30-40 minutes before the market close. Good luck to all decent and patient longs who will prevail and do extremely well here. No other healthcare company has what Clover offers at any price. Counterpart Health alone is an unexpected blessing and probably worth a whole lot more than just any average healthcare company. All of those other companies with share prices between $11 and $550 a share. The majority are losing money on top of it. Go figure. Here we are sitting at $2.90 and its a struggle! lol Have a look at this healthcare company doing nothing special not profitable and without our Counterpart Health. SP is $12 and name is Alignment Healthcare Inc ticker (ALHC)
New post from CLOV. Shes ready to blow.
https://www.reddit.com/r/CLOV/comments/1ffujsu/new_cfo_linkedin_post_today/#lightbox
In the near future those who didn't load bigtime here will regret it! IMO $2.50 CLOV tickets will be worth ten times more. After that a meteoric rise in the long-term future is inevitable. The potential of Clover Health/Counterpart Health is massive. IMO Risk/Reward is HUGE at the moment! This one is now a no brainer! The wait is finally about over. GLTA
Everything is being scalped with a few exceptions. "They" need cash. "They" need collateral.
My feeling is that this may be the dip before the RIP for many tickers.
Things behind the curtain are not looking very good for "them".
One domino to fall is all it will take.
Shorts had a substantial position in $CLOV back about 3-4 years ago. It was said that they scalped $CLOV and moved on.
I don't believe that for one second. In my opinion "they" never relinquished their short positions real or naked. This may still be a MEME
play like others "they" naked shorted.
Seems the only ticker not naked shorted is Berkshire Hathaway.
Just going to continue to HODL.
Good luck to the rest of you longs. This one has turned their business model around and is primed to go UP IMO.
Not counting on a squeeze. Let this one go up on fundamentals first. At some point "they" have to cover. Until then they have to deal with a
stellar business model.
First to cover will be the first to survive huge losses. All IMO.
A slow choke hold going on here. Criminal and obvious but it continues. CLOV shareholders will have their $day $month $year! Payback is a B! Won't this turn into the best cash making machine? RIGHT? In the near future there will be many who wish they had backed up the truck here at these levels. I just crossed the 100K share level. I guess we should be thankful for the opportunity right here right now! GLTA real live CLOV longs! We know what we own who we are and what is really going on here!
Good morning. I am more of a newbie to CLOV than most of you guys on the thread so I wasn't aware until last spring. I agree that the shorts are trying to knock us down but we had a fantastic 3 month run from below $1.00 to $3.90 I strongly feel we had profit-taking along with more shorting. This is not some flippers-style stock, it's a buy-and-hold term. Over time the shorts will cover and go away,and they will as we have way too many great things yet to be announced.
I'm bullish as well. And I still think $CLOV is naked shorted to the hilt.
Shorts never completely left this one. All IMHO.
She has a positive reaction to the Iowa News in A>H. Long-term buy and hold. I'm very BULLISH :)
The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest
FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc. (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa Clinic, P.C., one of the most highly regarded multispecialty healthcare groups in the United States. This deal positions The Iowa Clinic as one of Counterpart's anchor customers in the Midwest, as Counterpart drives a broader strategic expansion across the country. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”).
Founded in 1994, The Iowa Clinic is a benchmark for excellence in American healthcare, recognized as one of America's Top 100 Healthcare Providers by Becker's Hospital Review and a recipient of multiple Press Ganey Guardian of Excellence Awards for patient satisfaction. As the largest physician-owned multispecialty group in its community, with over 250 providers across more than 40 specialties, The Iowa Clinic is celebrated for its pioneering physician-governed, patient-centered model. It also has been recognized for its leadership in patient safety by the Leapfrog Group and quality care by the NCQA. The clinic is a frequent collaborator in national research and an early adopter of advanced diagnostic technologies, with its physicians regularly featured in Castle Connolly's list of America’s Top Doctors. Renowned for its clinical expertise and commitment to innovation, The Iowa Clinic consistently delivers world-class, patient-centered care.
Under the terms of the agreement, clinicians serving The Iowa Clinic’s Medicare Advantage and Medicare Shared Savings Program patients will use Counterpart Assistant, Counterpart Health’s cutting-edge cloud-based software platform. Additionally, the platform will be made available to The Iowa Clinic’s clinically integrated network partners throughout the Midwest. Counterpart will receive a per-member, per-month fee, as well as potential incentive payments contingent on achieving certain care management goals.
“Counterpart Assistant was engineered in one of the most challenging healthcare markets in the nation, attracting leading payors and provider groups dedicated to addressing the complex needs of patients in challenging markets,” said Andrew Toy, CEO of Clover Health. “The Iowa Clinic stands at the forefront of innovative, value-based care solutions, and we are confident our technology will deliver substantial clinical value to the hundreds of physicians within this distinguished provider group, as well as their Medicare patients.”
“We take great pride in being a leader in the adoption of innovative medical technologies and treatments, always with the aim of elevating the quality of care our patients receive,” said Ben Vallier, CEO of The Iowa Clinic, P.C. “Counterpart’s ability to harness clinical data to drive improved outcomes, combined with its intuitive design that understands the needs of practicing clinicians, stood out among other potential solutions, and makes it a perfect fit for our organization. We are very optimistic about the immediate and long-term clinical and financial value it will bring to our providers and patients alike.”
Built on technology originally developed by Clover Health, Counterpart Assistant is an AI-enabled solution designed to seamlessly integrate into physicians’ workflows, supporting earlier diagnosis and management of chronic diseases, and is currently used by over a thousand physicians as part of their daily workflow to enhance patient care. By leveraging real-time insights from more than a hundred data sources and utilizing over one hundred machine learning models, providers using Counterpart Assistant can identify, diagnose, and treat some of the most costly chronic diseases earlier. For example, Clover Health has seen over a 1,000 basis point medical cost ratio (MCR) differential between returning members of its Medicare Advantage plans whose primary care physicians (PCP) use Counterpart Assistant versus those members whose PCPs do not. As Counterpart’s largest customer, the success of Clover Health’s PPO-focused Medicare Advantage plans stand as a powerful testament to the value the technology can bring to plans and providers managing Medicare risk.
For companies interested in learning more about how Counterpart can reduce the total cost of care in value-based care models through advanced chronic disease management, visit www.counterparthealth.com.
About Counterpart Health
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI powered physician enablement platform. Counterpart Health’s flagship software platform, Counterpart Assistant, was incubated by Clover Health as Clover Assistant and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology. Counterpart Health extends the benefits of the data-driven technology platform outside of Clover Health’s Medicare Advantage plan to a wider audience, to enable enhanced patient outcomes and reduced healthcare costs nationwide. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
About The Iowa Clinic, P.C.
Formed in 1994, The Iowa Clinic is the largest independent, physician-owned multi-specialty group in the Des Moines community with more than 250 physicians and healthcare providers practicing in 40-plus specialties. The organiz
I’m actually hoping those who manipulate CLOV will push the price even lower. Many of you know I'm heavily vested in Clover Health, holding significant shares and options since my first buy in May 2021. It's been a wild ride, but the recent developments have been incredibly promising. Here’s why I’m embracing the possibility of CLOV being driven lower ahead of Q3:
Clover has already proven its concept with patented technology that stands out in the industry. The fact that larger insurers are facing challenges while we continue to improve demonstrates the competitive edge CLOV holds over established names in the Medicare Advantage space, such as Humana, UnitedHealth Group, and others. Humana has recently slashed profit projections due to unexpected rises in medical costs, while UnitedHealth Group has been dealing with legal battles over allegations of overbilling Medicare. These struggles highlight the growing pressures in the sector, yet Clover Health continues to show resilience and progress.
If the stock is pushed lower before our next earnings report and the update on our new SaaS revenue stream's profitability, it presents a strategic buying opportunity. Here’s a reminder of all CLOV has going for it following the last earnings report:
Clover will be the next big three in Healthcare and Electronic Health Records.
.
https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.reddit.com%2Fr%2FHealthcare_Anon%2Fs%2F1dfeLsFDtU&data=05%7C02%7C%7C645129117a734488321a08dccc236f1d%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638609699754792759%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=7fXMl9ei5jvUAhDZHRMrZjg4lAM2bn3nVWkACP8jQFc%3D&reserved=0
Good healthy retrace.
Look for a good entry point. Any ideas~?
TIA
here we gooooo!!
im a lady, and thx. 
Ladies and gentlemen, we gather here today to reflect on a unique group of individuals: those who made the bold decision to short Clover Health stock. While their actions were driven by strategy, calculation, and perhaps a dash of skepticism, their journey became a testament to the unpredictable nature of markets and the complexities of betting against innovation.
These short-sellers embarked on their path with conviction, believing they had identified a weakness or a misstep in Clover Health’s trajectory. They combed through financials, analyzed market trends, and held firm in their belief that this company’s rise was unsustainable. In doing so, they played an essential role in keeping the market in balance, reminding us all that for every bull, there must be a bear.
But as time went on, and Clover Health showed resilience, adaptability, and growth, these short-sellers found themselves facing the harsh realities of a market that can often defy even the best-laid plans. What began as a calculated gamble became, for many, an expensive lesson in the power of innovation and perseverance. Clover Health didn’t falter the way they expected. Instead, it evolved, and with it, the fortunes of those betting against it changed.
In this reflection, we do not mourn their losses but celebrate their participation in the grand theater of the stock market, where risks are taken, lessons are learned, and the future remains unwritten. For every short-seller, there’s a story of ambition and belief, and today, we honor their place in that story.
May they find peace in the knowledge that in this dynamic, ever-shifting market, they played their part. And as Clover Health continues to rise, may we all remember the value of conviction – whether we stand with the bulls or the bears.
Rest easy, short-sellers. You gave it your all.
"They" cannot afford to let $CLOV run just like many other tickers they are also suppressing.
grabbed some on the dip today, hi all.
Let's go $CLOV~!
They are having a hard time stopping this.
I've been tracking the MCR (Medical Cost Ratio) trends closely, and here's the latest update on projections for Q3 and Q4 of 2024. The guidance range has been adjusted to ensure that the full-year MCR stays within the 77%-79% target.
https://www.reddit.com/r/CLOV/comments/1ewrazv/mcr_2024_is_conservative_guidance_setting_up_for/
In my opinion adding here around $3 is an absolute no brainer. I have 40K shares average at 1.34. I am staring a new account now around $3 so that it won't average my other account up. To me $3 is the new bottom safe area. In the near future newcomers will be very happy to buy CLOV at $5 including Wall Street whales for their clients etc. Counterpart Health/Clover Health are going to be massive! I MEAN MASSIVE!
GOOD LUCK TO ALL CLOVER LONGS. THE FUN IS JUST BEGINNING!
Beautiful read! Thanks for the link.😷
AI
